Aarkstore - Metastatic Melanoma-Global API Manufacturers

1. Category : Pharmaceuticals and Healthcare Aarkstore - Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

2. Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Melanoma. A key objective of DelveInsights report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Metastatic Melanoma. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Metastatic Melanoma. While the leading brands, companies and chemicals are considered thoroughly, DelveInsights report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. The research analysis also presents the global sales forecasts data till 2016. Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/98052/metastatic-melanoma-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2015

3. Data Sources The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

4. Scope • A snapshot of the global Market therapeutics scenario for Metastatic Melanoma. • A review of the marketed products under prescription for Metastatic Melanoma, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Metastatic Melanoma with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Metastatic Melanoma drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Metastatic Melanoma drugs. • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Metastatic Melanoma drugs.

5. Reasons to buy • Evaluate the marketing status and exclusivity details of Metastatic Melanoma key products to exploit opportunities for generic drug development opportunities. • Identify and understand important and diverse types of therapeutics under Phase III development for Metastatic Melanoma. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Metastatic Melanoma.

6. Table of Content • Evaluate the marketing status and exclusivity details of Metastatic Melanoma key products to exploit opportunities for generic drug development opportunities. • Identify and understand important and diverse types of therapeutics under Phase III development for Metastatic Melanoma. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Metastatic Melanoma. • API intelligence over marketed drugs for Metastatic Melanoma and gaining primary intelligence over active ingredients manufacturers across the globe. • API intelligence over leading Phase III Pipeline drugs. • Drugs Market Data and Forecasted Sales Figure (2012-2016) • Marketed Drugs for Metastatic Melanoma • Drug Name • Drug Description

7. List of Tables • Metastatic Melanoma Therapeutic Market, US, Marketed Drugs by Application Type, 2015 • Metastatic Melanoma Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015 • Metastatic Melanoma Therapeutic Market, US, (Year), 2015 • Metastatic Melanoma Marketed Drugs, API Manufacturers by US DMF Status, 2015 • Metastatic Melanoma Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Metastatic Melanoma Drugs, API Manufacturers, Europe by Country, 2015 • Metastatic Melanoma Drugs, API Manufacturers, India by State, 2015 • Metastatic Melanoma Drugs, API Manufacturers, China by Province, 2015 • Metastatic Melanoma Drugs, API Manufacturers by Geography 2015

8. List of Figures • Metastatic Melanoma Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015 • Metastatic Melanoma Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015 • Metastatic Melanoma Therapeutic Market, US, (Year), 2015 • Metastatic Melanoma Marketed Drugs, API Manufacturers by US DMF Status (%), 2015 • Metastatic Melanoma Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Metastatic Melanoma Drugs, API Manufacturers, Europe by Country, 2015 • Metastatic Melanoma Drugs, API Manufacturers, India by State, 2015 • Metastatic Melanoma Drugs, API Manufacturers, China by Province, 2015 • Metastatic Melanoma Drugs, API Manufacturers by Geography 2015

9. Related reports: • Pharmaceutical Industry in China • Healthcare IT Market in India 2015-2019 • Annual Report Analysis of Listed Amino Acid Companies in China • Vitamin Price in China • Vitamin Industry Trend in China • Global POC Diagnostics Market 2015-2019 • Global POC Lipid Testing Market 2015-2019 • Global Sexual Wellness Market 2015-2019 • Healthcare IT Market in Africa 2015-2019 • Healthcare IT Market in India 2015-2019

10. Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Published: Feb 2015 | 100 Pages Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Melanoma. Price

11. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news